Chapter 1. Research Background
1.1. Research Objectives
1.2. Market Definition
1.3. Research Scope
1.3.1. Market Segmentation by Product
1.3.2. Market Segmentation by Application
1.3.3. Market Segmentation by End User
1.3.4. Market Segmentation by Geography
1.3.5. Analysis Period
1.3.6. Market Data Reporting Unit
1.3.6.1. Value
1.4. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.2.1. Breakdown of Primary Research Respondents
2.2.1.1. By region
2.2.1.2. By industry participants
2.2.1.3. By company type
2.3. Market Size Estimation
2.4. Market Breakdown and Data Triangulation
2.5. Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1. Market Segmentation
4.1.1. Overview by Product
4.1.1.1. Consumables
4.1.1.1.1. Reagents
4.1.1.1.2. Assay kits
4.1.1.1.2.1. Reporter gene assays
4.1.1.1.2.2. Cell growth assays
4.1.1.1.2.3. Second messenger assays
4.1.1.1.2.4. Cell death assays
4.1.1.1.2.5. Other assays
4.1.1.1.3. Microplates
4.1.1.1.4. Cell lines
4.1.1.1.4.1. Immortalized cell lines
4.1.1.1.4.2. Primary cell lines
4.1.1.1.4.3. Stem cell lines
4.1.1.1.5. Probes and labels
4.1.1.1.6. Other consumables
4.1.1.2. Instruments
4.1.1.3. Services
4.1.1.4. Software
4.1.2. Overview by Application
4.1.2.1. Drug discovery
4.1.2.2. Research studies
4.1.2.3. ADME analysis
4.1.2.4. Predictive toxicology
4.1.2.5. Other applications
4.1.3. Overview by End User
4.1.3.1. Pharmaceutical & biotechnology companies
4.1.3.2. Academic & government institutions
4.1.3.3. Contract research organizations
4.1.3.4. Others
4.2. Market Dynamics
4.2.1. Trends
4.2.2. Drivers
4.2.2.1. Impact analysis of drivers on market forecast
4.2.3. Restraints
4.2.3.1. Impact analysis of restraints on market forecast
4.2.4. Opportunities
4.3. Porter’s Five Forces Analysis
Chapter 5. Market Size and Forecast by Product
5.1. Consumables
5.1.1. Reagents
5.1.2. Assay Kits
5.1.2.1. Reporter gene assays
5.1.2.2. Cell growth assays
5.1.2.3. Second messenger assays
5.1.2.4. Cell death assays
5.1.2.5. Other assays
5.1.3. Microplates
5.1.4. Cell Lines
5.1.4.1. Immortalized cell lines
5.1.4.2. Primary cell lines
5.1.4.3. Stem cell lines
5.1.5. Probes and Labels
5.1.6. Other Consumables
5.2. Instruments
5.3. Services
5.4. Software
Chapter 6. Market Size and Forecast by Application
6.1. Drug Discovery
6.2. Research Studies
6.3. ADME Analysis
6.4. Predictive Toxicology
6.5. Other Applications
Chapter 7. Market Size and Forecast by End User
7.1. Pharmaceutical & Biotechnology Companies
7.2. Academic & Government Institutions
7.3. Contract Research Organizations
7.4. Others
Chapter 8. Market Size and Forecast by Geography
8.1. North America Cell Based Assays Market
8.1.1. By Product
8.1.2. By Application
8.1.3. By End User
8.1.4. By Country – The U.S. and Canada
8.2. Europe Cell Based Assays Market
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country – France, The U.K., Germany, Spain, Italy and Rest of Europe
8.3. Asia-Pacific Cell Based Assays Market
8.3.1. By Product
8.3.2. By Application
8.3.3. By End User
8.3.4. By Country – China, Japan, India and Rest of Asia-Pacific
8.4. Latin America Cell Based Assays Market
8.4.1. By Product
8.4.2. By Application
8.4.3. By End User
8.4.4. By Country – Brazil, Mexico and Rest of Latin America
8.5. Middle East & Africa Cell Based (MEA) Assays Market
8.5.1. By Product
8.5.2. By Application
8.5.3. By End User
8.5.4. By Country - UAE, South Africa and Rest of MEA
Chapter 9. Competitive Landscape
9.1. Competitive Analysis of Key Players
9.2. Global Strategic Developments
Chapter 10. Company Profiles
10.1. Becton, Dickinson and Company
10.1.1. Business Overview
10.1.2. Product and Service Offerings
10.1.3. Key Financial Summary
10.1.4. Strategic Growth Plan
10.2. Danaher Corporation
10.2.1. Business Overview
10.2.2. Product and Service Offerings
10.2.3. Key Financial Summary
10.2.4. Strategic Growth Plan
10.3. Thermo Fisher Scientific Inc.
10.3.1. Business Overview
10.3.2. Product and Service Offerings
10.3.3. Key Financial Summary
10.3.4. Strategic Growth Plan
10.4. GE Healthcare Life Sciences
10.4.1. Business Overview
10.4.2. Product and Service Offerings
10.4.3. Key Financial Summary
10.4.4. Strategic Growth Plan
10.5. Merck KGaA
10.5.1. Business Overview
10.5.2. Product and Service Offerings
10.5.3. Key Financial Summary
10.5.4. Strategic Growth Plan
10.6. PerkinElmer Inc.
10.6.1. Business Overview
10.6.2. Product and Service Offerings
10.6.3. Key Financial Summary
10.6.4. Strategic Growth Plan
10.7. Cell Signaling Technologies Inc.
10.7.1. Business Overview
10.7.2. Product and Service Offerings
10.7.3. Key Financial Summary
10.7.4. Strategic Growth Plan
10.8. Promega Corporation
10.8.1. Business Overview
10.8.2. Product and Service Offerings
10.8.3. Key Financial Summary
10.8.4. Strategic Growth Plan
10.9. Cisbio Bioassays
10.9.1. Business Overview
10.9.2. Product and Service Offerings
10.9.3. Key Financial Summary
10.9.4. Strategic Growth Plan
10.10. Cell Biolabs, Inc.
10.10.1. Business Overview
10.10.2. Product and Service Offerings
10.10.3. Key Financial Summary
10.10.4. Strategic Growth Plan
10.11. Discoverx Corporation
10.11.1. Business Overview
10.11.2. Product and Service Offerings
10.11.3. Key Financial Summary
10.11.4. Strategic Growth Plan
*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.
Chapter 11. Appendix
11.1. Abbreviations
